Clinical Trials Browser

INDUSTRY × Interventional × Hormone Sensitive Prostate Cancer × Clear all

NCT04995042 2023-09-21

A Phase 1 Dose Escalation and Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate Cancer

Phase 1 Completed

Hormone Sensitive Prostate Cancer